StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

PDS Biotechnology's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.78M. For fiscal 2025 it was -$27.75M. The highest annual figure on record is -$1.57M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.75M–
FY2024Dec 31, 2024-$35.03M–
FY2023Dec 31, 2023-$33.64M–
FY2022Dec 31, 2022-$25.71M–
FY2021Dec 31, 2021-$12.49M–
FY2020Dec 31, 2020-$13.15M–
FY2019Dec 31, 2019-$18.07M–
FY2018Dec 31, 2018-$1.57M–
FY2017Dec 31, 2017-$40.70M–
FY2016Dec 31, 2016-$32.19M–
FY2015Dec 31, 2015-$21.75M–
FY2014Dec 31, 2014-$9.72M–
FY2013Dec 31, 2013-$8.04M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.79M–
Q1 FY2026Mar 31, 2026-$4.37M–
Q4 FY2025Dec 31, 2025-$3.70M–
Q3 FY2025Sep 30, 2025-$5.92M–
Q2 FY2025Jun 30, 2025-$9.10M–
Q1 FY2025Mar 31, 2025-$9.03M–
Q4 FY2024Dec 31, 2024-$8.23M–
Q3 FY2024Sep 30, 2024-$8.00M–
Q2 FY2024Jun 30, 2024-$8.86M–
Q1 FY2024Mar 31, 2024-$9.94M–
Q4 FY2023Dec 31, 2023-$8.46M–
Q3 FY2023Sep 30, 2023-$7.18M–
Q2 FY2023Jun 30, 2023-$4.81M–
Q1 FY2023Mar 31, 2023-$13.19M–
Q4 FY2022Dec 31, 2022-$7.53M–
Q3 FY2022Sep 30, 2022-$5.89M–
Q2 FY2022Jun 30, 2022-$5.92M-725.5%
Q1 FY2022Mar 31, 2022-$6.37M–
Q4 FY2021Dec 31, 2021-$4.50M–
Q3 FY2021Sep 30, 2021-$5.13M–
Q2 FY2021Jun 30, 2021$946.23K–
Q1 FY2021Mar 31, 2021-$3.80M–
Q4 FY2020Dec 31, 2020-$4.63M–
Q3 FY2020Sep 30, 2020-$1.25M–
Q2 FY2020Jun 30, 2020-$4.10M–
Q1 FY2020Mar 31, 2020-$3.16M–
Q4 FY2019Dec 31, 2019-$5.52M–
Q3 FY2019Sep 30, 2019-$4.33M–
Q2 FY2019Jun 30, 2019-$4.86M–
Q1 FY2019Mar 31, 2019-$3.37M–
Q4 FY2018Dec 31, 2018-$317.63K–
Q3 FY2018Sep 30, 2018-$432.25K–
Q2 FY2018Jun 30, 2018-$415.37K–
Q1 FY2018Mar 31, 2018-$404.34K–
Q4 FY2017Dec 31, 2017-$9.24M–
Q3 FY2017Sep 30, 2017-$11.40M–
Q2 FY2017Jun 30, 2017-$9.28M–
Q1 FY2017Mar 31, 2017-$10.77M–
Q4 FY2016Dec 31, 2016-$6.05M–
Q3 FY2016Sep 30, 2016-$8.79M–

More PDS Biotechnology figures

See a number that looks wrong?